Reply to the Letter to the Editor “Anemia of Chronic Kidney Disease: Which Therapeutics Are Available?” Regarding the Article “Anemia in Chronic Kidney Disease: The State of the Art”
DOI:
https://doi.org/10.20344/amp.20651Keywords:
Anemia/drug therapy, Prolyl-Hydroxylase Inhibitors/therapeutic use, Renal Insufficiency, Chronic/complicationsAbstract
N/a.
Downloads
References
Condeço S, Marques da Silva B. Anemia of chronic kidney disease: which therapeutics are available? Acta Med Port. 2023;36:296-303.
Portugal. Portaria n.º 255/2018. Diário da República, I série, n.º 173 (2018/09/07). p.4707.
Portugal. Despacho n.º 6370/2002. Diário da República, II série, n.º 69 (2002/03/22).
Farinha A, Robalo Nunes A, Mairos J, Fonseca C. Anemia da doença renal crónica: o estado da arte. Acta Med Port. 2022;35:758-64.
US Food & Drug Administration. FDA Briefing Document: Cardiovascular and Renal Drugs Advisory Committee Meeting July 15, 2021. Roxadustat. [consultado 2023 set 12]. Disponível em: https://www.fda.gov/media/150728/download.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Acta Médica Portuguesa
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.
